Unlocking proteomic heterogeneity in complex diseases through visual analytics

Suresh Bhavnani, Bryant Dang, Gowtham Bellala, Rohit Divekar, Shyam Visweswaran, Allan R. Brasier, Alex Kurosky

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Despite years of preclinical development, biological interventions designed to treat complex diseases such as asthma often fail in phase III clinical trials. These failures suggest that current methods to analyze biomedical data might be missing critical aspects of biological complexity such as the assumption that cases and controls come from homogeneous distributions. Here we discuss why and how methods from the rapidly evolving field of visual analytics can help translational teams (consisting of biologists, clinicians, and bioinformaticians) to address the challenge of modeling and inferring heterogeneity in the proteomic and phenotypic profiles of patients with complex diseases. Because a primary goal of visual analytics is to amplify the cognitive capacities of humans for detecting patterns in complex data, we begin with an overview of the cognitive foundations for the field of visual analytics. Next, we organize the primary ways in which a specific form of visual analytics called networks has been used to model and infer biological mechanisms, which help to identify the properties of networks that are particularly useful for the discovery and analysis of proteomic heterogeneity in complex diseases. We describe one such approach called subject-protein networks, and demonstrate its application on two proteomic datasets. This demonstration provides insights to help translational teams overcome theoretical, practical, and pedagogical hurdles for the widespread use of subject-protein networks for analyzing molecular heterogeneities, with the translational goal of designing biomarker-based clinical trials, and accelerating the development of personalized approaches to medicine.

Original languageEnglish (US)
Pages (from-to)1405-1418
Number of pages14
JournalProteomics
Volume15
Issue number8
DOIs
StatePublished - Apr 1 2015

Fingerprint

Proteomics
Visual Fields
Biological Models
Phase III Clinical Trials
Biomarkers
Medicine
Proteins
Demonstrations
Asthma
Clinical Trials
Datasets

Keywords

  • Bioinformatics
  • Molecular and clinical profiles
  • Network analysis
  • Personalized medicine
  • Proteomic heterogeneity
  • Subject-Protein Networks

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry

Cite this

Bhavnani, S., Dang, B., Bellala, G., Divekar, R., Visweswaran, S., Brasier, A. R., & Kurosky, A. (2015). Unlocking proteomic heterogeneity in complex diseases through visual analytics. Proteomics, 15(8), 1405-1418. https://doi.org/10.1002/pmic.201400451

Unlocking proteomic heterogeneity in complex diseases through visual analytics. / Bhavnani, Suresh; Dang, Bryant; Bellala, Gowtham; Divekar, Rohit; Visweswaran, Shyam; Brasier, Allan R.; Kurosky, Alex.

In: Proteomics, Vol. 15, No. 8, 01.04.2015, p. 1405-1418.

Research output: Contribution to journalArticle

Bhavnani, S, Dang, B, Bellala, G, Divekar, R, Visweswaran, S, Brasier, AR & Kurosky, A 2015, 'Unlocking proteomic heterogeneity in complex diseases through visual analytics', Proteomics, vol. 15, no. 8, pp. 1405-1418. https://doi.org/10.1002/pmic.201400451
Bhavnani S, Dang B, Bellala G, Divekar R, Visweswaran S, Brasier AR et al. Unlocking proteomic heterogeneity in complex diseases through visual analytics. Proteomics. 2015 Apr 1;15(8):1405-1418. https://doi.org/10.1002/pmic.201400451
Bhavnani, Suresh ; Dang, Bryant ; Bellala, Gowtham ; Divekar, Rohit ; Visweswaran, Shyam ; Brasier, Allan R. ; Kurosky, Alex. / Unlocking proteomic heterogeneity in complex diseases through visual analytics. In: Proteomics. 2015 ; Vol. 15, No. 8. pp. 1405-1418.
@article{a9935f6879ea436e90cf76498c1c273c,
title = "Unlocking proteomic heterogeneity in complex diseases through visual analytics",
abstract = "Despite years of preclinical development, biological interventions designed to treat complex diseases such as asthma often fail in phase III clinical trials. These failures suggest that current methods to analyze biomedical data might be missing critical aspects of biological complexity such as the assumption that cases and controls come from homogeneous distributions. Here we discuss why and how methods from the rapidly evolving field of visual analytics can help translational teams (consisting of biologists, clinicians, and bioinformaticians) to address the challenge of modeling and inferring heterogeneity in the proteomic and phenotypic profiles of patients with complex diseases. Because a primary goal of visual analytics is to amplify the cognitive capacities of humans for detecting patterns in complex data, we begin with an overview of the cognitive foundations for the field of visual analytics. Next, we organize the primary ways in which a specific form of visual analytics called networks has been used to model and infer biological mechanisms, which help to identify the properties of networks that are particularly useful for the discovery and analysis of proteomic heterogeneity in complex diseases. We describe one such approach called subject-protein networks, and demonstrate its application on two proteomic datasets. This demonstration provides insights to help translational teams overcome theoretical, practical, and pedagogical hurdles for the widespread use of subject-protein networks for analyzing molecular heterogeneities, with the translational goal of designing biomarker-based clinical trials, and accelerating the development of personalized approaches to medicine.",
keywords = "Bioinformatics, Molecular and clinical profiles, Network analysis, Personalized medicine, Proteomic heterogeneity, Subject-Protein Networks",
author = "Suresh Bhavnani and Bryant Dang and Gowtham Bellala and Rohit Divekar and Shyam Visweswaran and Brasier, {Allan R.} and Alex Kurosky",
year = "2015",
month = "4",
day = "1",
doi = "10.1002/pmic.201400451",
language = "English (US)",
volume = "15",
pages = "1405--1418",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "8",

}

TY - JOUR

T1 - Unlocking proteomic heterogeneity in complex diseases through visual analytics

AU - Bhavnani, Suresh

AU - Dang, Bryant

AU - Bellala, Gowtham

AU - Divekar, Rohit

AU - Visweswaran, Shyam

AU - Brasier, Allan R.

AU - Kurosky, Alex

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Despite years of preclinical development, biological interventions designed to treat complex diseases such as asthma often fail in phase III clinical trials. These failures suggest that current methods to analyze biomedical data might be missing critical aspects of biological complexity such as the assumption that cases and controls come from homogeneous distributions. Here we discuss why and how methods from the rapidly evolving field of visual analytics can help translational teams (consisting of biologists, clinicians, and bioinformaticians) to address the challenge of modeling and inferring heterogeneity in the proteomic and phenotypic profiles of patients with complex diseases. Because a primary goal of visual analytics is to amplify the cognitive capacities of humans for detecting patterns in complex data, we begin with an overview of the cognitive foundations for the field of visual analytics. Next, we organize the primary ways in which a specific form of visual analytics called networks has been used to model and infer biological mechanisms, which help to identify the properties of networks that are particularly useful for the discovery and analysis of proteomic heterogeneity in complex diseases. We describe one such approach called subject-protein networks, and demonstrate its application on two proteomic datasets. This demonstration provides insights to help translational teams overcome theoretical, practical, and pedagogical hurdles for the widespread use of subject-protein networks for analyzing molecular heterogeneities, with the translational goal of designing biomarker-based clinical trials, and accelerating the development of personalized approaches to medicine.

AB - Despite years of preclinical development, biological interventions designed to treat complex diseases such as asthma often fail in phase III clinical trials. These failures suggest that current methods to analyze biomedical data might be missing critical aspects of biological complexity such as the assumption that cases and controls come from homogeneous distributions. Here we discuss why and how methods from the rapidly evolving field of visual analytics can help translational teams (consisting of biologists, clinicians, and bioinformaticians) to address the challenge of modeling and inferring heterogeneity in the proteomic and phenotypic profiles of patients with complex diseases. Because a primary goal of visual analytics is to amplify the cognitive capacities of humans for detecting patterns in complex data, we begin with an overview of the cognitive foundations for the field of visual analytics. Next, we organize the primary ways in which a specific form of visual analytics called networks has been used to model and infer biological mechanisms, which help to identify the properties of networks that are particularly useful for the discovery and analysis of proteomic heterogeneity in complex diseases. We describe one such approach called subject-protein networks, and demonstrate its application on two proteomic datasets. This demonstration provides insights to help translational teams overcome theoretical, practical, and pedagogical hurdles for the widespread use of subject-protein networks for analyzing molecular heterogeneities, with the translational goal of designing biomarker-based clinical trials, and accelerating the development of personalized approaches to medicine.

KW - Bioinformatics

KW - Molecular and clinical profiles

KW - Network analysis

KW - Personalized medicine

KW - Proteomic heterogeneity

KW - Subject-Protein Networks

UR - http://www.scopus.com/inward/record.url?scp=84926443068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926443068&partnerID=8YFLogxK

U2 - 10.1002/pmic.201400451

DO - 10.1002/pmic.201400451

M3 - Article

VL - 15

SP - 1405

EP - 1418

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 8

ER -